Copyright
©The Author(s) 2016.
World J Hematol. May 6, 2016; 5(2): 51-60
Published online May 6, 2016. doi: 10.5315/wjh.v5.i2.51
Published online May 6, 2016. doi: 10.5315/wjh.v5.i2.51
Activator | miRNA reduced | miRNA overexpressed | Target increased | Target decreased | Effect | Ref. |
Deletion, other | miR-15a, miR-16 | AKT, S6, MAPK, MAP3KIP3 (TAB3) | Increased proliferation and survival | [30] | ||
miR-30-5p family | BCL9 | Increased Wnt/β-catenin activation | [32] | |||
c-Myc (reduced) | miR-17/92 cluster | Bim | Increased apoptosis | [36,40] | ||
Sp-1 (increased) | miR-29b | Sp-1, CDK6, Mcl-1, caspase-3, Rb phosphorylation | [41,42] | |||
miR-34a, miR-192, miR-194, miR-215 | MDM2, IGF-1 | Cell proliferation | [34] | |||
miR-19a/b | SOCS1, Bim | Reduced apoptosis | [36] | |||
miR-181a/b, miR-32 | PCAF | Reduced p53 acetylation | [36] | |||
miR-221, miR-222 | P27Kip1, p57Kip2, PUMA, PTEN | Increased proliferation | [35] | |||
IL-6 | miR-21 | STAT-3 | [37,38] |
Target increased | Target reduced | Effect (anti-angiogenic) | Effect (pro-angiogenic) | Ref. | |
miRNA reduced | |||||
miR-15a, miR-16, miR-145 | VEGF, ERK pathway, AKT pathway | Reduced EC growth, reduced ability to form capillary structures | [30,31,48] | ||
miR-199a-5p | HIF-1α, SIRT-1 | Increased expression of VEGF, IL-8, bFGF, CXCL12, MMP-2 | [47] | ||
miRNA increased | |||||
Let 7 family | Thrombospondin-1, TIMP-1 | Inhibiting anti-angiogenic factors | [48] | ||
miR-92-1 | Angiopoietin-like protein 1 | Inhibit anti-angiogenic protein | [48] | ||
miR-135b | FIH-1 | Alleviate HIF-1α inhibition | [45] |
- Citation: Rahat MA, Preis M. Role of microRNA in regulation of myeloma-related angiogenesis and survival. World J Hematol 2016; 5(2): 51-60
- URL: https://www.wjgnet.com/2218-6204/full/v5/i2/51.htm
- DOI: https://dx.doi.org/10.5315/wjh.v5.i2.51